Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials.
Franklin
S M
SM
Evans Memorial Department of Clinical Research, Boston University Medical Center, MA.
Faxon
D P
DP
D015906:Angioplasty, Balloon, Coronary; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D000925:Anticoagulants / Q000008:administration & dosage; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000628:therapy*; D005395:Fish Oils / Q000008:administration & dosage; D006801:Humans; D008148:Lovastatin / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence
D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D005395:Fish Oils; D010975:Platelet Aggregation Inhibitors; D008148:Lovastatin; D008775:Methylprednisolone